Kim D - Search Results

1

Current Burden of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Among US Adults, 2017-2023.

Kim D, Danpanichkul P, Wijarnpreecha K, Cholankeril G, Loomba R, Ahmed A. Kim D, et al. Aliment Pharmacol Ther. 2025 Jan 11. doi: 10.1111/apt.18501. Online ahead of print. Aliment Pharmacol Ther. 2025. PMID: 39797575

2

Depression is associated with non-alcoholic fatty liver disease among adults in the United States.

Kim D, Yoo ER, Li AA, Tighe SP, Cholankeril G, Harrison SA, Ahmed A. Kim D, et al. Aliment Pharmacol Ther. 2019 Sep;50(5):590-598. doi: 10.1111/apt.15395. Epub 2019 Jul 22. Aliment Pharmacol Ther. 2019. PMID: 31328300

3

Trends in aetiology-based hospitalisation for cirrhosis before and during the COVID-19 pandemic in the United States.

Kim D, Perumpail BJ, Wijarnpreecha K, Manikat R, Cholankeril G, Ahmed A. Kim D, et al. Aliment Pharmacol Ther. 2023 Jul;58(2):218-228. doi: 10.1111/apt.17547. Epub 2023 May 15. Aliment Pharmacol Ther. 2023. PMID: 37189243

4

What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside.

Danpanichkul P, Suparan K, Kim D, Wijarnpreecha K. Danpanichkul P, et al. Among authors: kim d. J Clin Med. 2024 Jan 3;13(1):278. doi: 10.3390/jcm13010278. J Clin Med. 2024. PMID: 38202285 Free PMC article. Review.

5

Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States.

Manikat R, Kim SU, Ahmed A, Kim D. Manikat R, et al. Among authors: kim su, kim d. Aliment Pharmacol Ther. 2024 Mar;59(6):789-790. doi: 10.1111/apt.17871. Aliment Pharmacol Ther. 2024. PMID: 38401138 No abstract available.

6

Editorial: Using machine learning to predict significant fibrosis in metabolic dysfunction-associated steatotic liver disease.

Manikat R, Ahmed A, Kim D. Manikat R, et al. Among authors: kim d. Aliment Pharmacol Ther. 2024 Apr;59(7):893-895. doi: 10.1111/apt.17902. Aliment Pharmacol Ther. 2024. PMID: 38462684 No abstract available.

7

The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults.

Perumpail BJ, Manikat R, Wijarnpreecha K, Cholankeril G, Ahmed A, Kim D. Perumpail BJ, et al. Among authors: kim d. J Pediatr Gastroenterol Nutr. 2024 Jul;79(1):110-118. doi: 10.1002/jpn3.12219. Epub 2024 Apr 16. J Pediatr Gastroenterol Nutr. 2024. PMID: 38623942

8

Steatotic liver disease-associated all-cause/cause-specific mortality in the United States.

Kim D, Wijarnpreecha K, Cholankeril G, Ahmed A. Kim D, et al. Aliment Pharmacol Ther. 2024 Jul;60(1):33-42. doi: 10.1111/apt.18011. Epub 2024 Apr 22. Aliment Pharmacol Ther. 2024. PMID: 38649335

9

Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality.

Kim D, Manikat R, Wijarnpreecha K, Cholankeril G, Ahmed A. Kim D, et al. J Gastroenterol Hepatol. 2024 Sep;39(9):1950-1956. doi: 10.1111/jgh.16608. Epub 2024 May 13. J Gastroenterol Hepatol. 2024. PMID: 38740513

10

Financial hardship and cost-related nonadherence to medication in patients with liver disease in the United States.

Kim D, Manikat R, Wijarnpreecha K, Ahmed A. Kim D, et al. Aliment Pharmacol Ther. 2024 Aug;60(4):492-502. doi: 10.1111/apt.18122. Epub 2024 Jun 12. Aliment Pharmacol Ther. 2024. PMID: 38864288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,802 results

Search Page

Filters